Babar Bashir
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 32
- Cancer Immunotherapy and Biomarkers 11
- Pancreatic and Hepatic Oncology Research 9
- CAR-T cell therapy research 6
- Colorectal Cancer Treatments and Studies 4
-
- Advanced Breast Cancer Therapies 6
- Co-authors
- Adam E. Snook (10 shared papers)Walter K. Kraft (4 shared papers)Douglas F. Stickle (1 shared paper)Inna Chervoneva (1 shared paper)Scott A. Waldman (6 shared papers)Melissa Wilson (1 shared paper)Jeffrey A. Rappaport (3 shared papers)Mary Naglak (1 shared paper)
- Journals
- Journal of Clinical Oncology (17 papers)Annals of Oncology (9 papers)Cancer Biology & Therapy (4 papers)Cancer Research (3 papers)Clinical and Translational Science (2 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Babar Bashir
61 papers receiving 436 citations
Peers
Comparison fields: 5 of 72
- Oncology 158
- Internal Medicine 15
- Immunology 83
- Hepatology 17
- Cancer Research 29
Countries citing papers authored by Babar Bashir
This map shows the geographic impact of Babar Bashir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Babar Bashir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Babar Bashir more than expected).
Fields of papers citing papers by Babar Bashir
This network shows the impact of papers produced by Babar Bashir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Babar Bashir. The network helps show where Babar Bashir may publish in the future.
Co-authors
The 25 scholars most cited alongside Babar Bashir, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 31 | |
| 2 | 2020 | 27 | |
| 3 | 2024 | 24 | |
| 4 | 2024 | 23 | |
| 5 | 2023 | 23 | |
| 6 | 2019 | 19 | |
| 7 | 2016 | 18 | |
| 8 | 2019 | 17 | |
| 9 | 2022 | 16 | |
| 10 | 2017 | 14 | |
| 11 | 2020 | 13 | |
| 12 | 2021 | 13 | |
| 13 | 2019 | 13 | |
| 14 | 2013 | 13 | |
| 15 | 2015 | 13 | |
| 16 | 2022 | 13 | |
| 17 | 2021 | 11 | |
| 18 | 2024 | 10 | |
| 19 | 2023 | 10 | |
| 20 | 2022 | 9 |
About Babar Bashir
Babar Bashir is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Surgery and Molecular Biology, having authored 70 papers that have together received 447 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Pancreatic and Hepatic Oncology Research (9 papers), Immunotherapy and Immune Responses (7 papers), Cancer Genomics and Diagnostics (6 papers), Advanced Breast Cancer Therapies (6 papers), CAR-T cell therapy research (6 papers), Colorectal Cancer Treatments and Studies (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). The work is most often cited by research in Oncology (158 citations), Internal Medicine (15 citations), Immunology (83 citations), Hepatology (17 citations) and Cancer Research (29 citations). Babar Bashir has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Adam E. Snook, Walter K. Kraft, Douglas F. Stickle, Inna Chervoneva, Scott A. Waldman, Melissa Wilson, Jeffrey A. Rappaport, Mary Naglak, John C. Flickinger and Doron Schneider. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Biology & Therapy, Cancer Research and Clinical and Translational Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.